Cargando…

Four-year effects of exercise on fatigue and physical activity in patients with cancer

BACKGROUND: In the earlier randomized controlled Physical Activity during Cancer Treatment (PACT) study, we found beneficial effects of an 18-week supervised exercise program on fatigue in patients with newly diagnosed breast or colon cancer undergoing adjuvant treatment. The present study assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witlox, Lenja, Hiensch, Anouk E., Velthuis, Miranda J., Steins Bisschop, Charlotte N., Los, Maartje, Erdkamp, Frans L. G., Bloemendal, Haiko J., Verhaar, Marlies, ten Bokkel Huinink, Daan, van der Wall, Elsken, Peeters, Petra H. M., May, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992660/ https://www.ncbi.nlm.nih.gov/pubmed/29879968 http://dx.doi.org/10.1186/s12916-018-1075-x

Ejemplares similares

Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study
por: May, Anne M, et al.
Publicado: (2017)

Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial
por: Travier, Noémie, et al.
Publicado: (2015)

Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study
por: Witlox, Lenja, et al.
Publicado: (2019)

Socio-ecological correlates of physical activity in breast and colon cancer survivors 4 years after participation in a randomized controlled exercise trial (PACT study)
por: Hiensch, Anouk E., et al.
Publicado: (2020)

Control Group Design, Contamination and Drop-Out in Exercise Oncology Trials: A Systematic Review
por: Steins Bisschop, Charlotte N., et al.
Publicado: (2015)

Palmar Fasciitis and Polyarthritis Syndrome: A Rare Paraneoplastic Syndrome in a Patient With Prostate Carcinoma
por: de Boer, Anouk G., et al.
Publicado: (2020)

Inflammation Mediates Exercise Effects on Fatigue in Patients with Breast Cancer
por: HIENSCH, ANOUK E., et al.
Publicado: (2021)

Perceived facilitators and barriers by esophageal cancer survivors participating in a post-treatment exercise program
por: van Vulpen, Jonna K., et al.
Publicado: (2023)

Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial
por: Witlox, Lenja, et al.
Publicado: (2019)

Sense of coherence and its relationship to participation, cancer-related fatigue, symptom burden, and quality of life in women with breast cancer participating in the OptiTrain exercise trial
por: Hiensch, Anouk E, et al.
Publicado: (2020)

Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
por: Hiensch, Anouk E., et al.
Publicado: (2019)

Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer
por: Terwogt, J M M, et al.
Publicado: (1999)

Plate fixation versus intramedullary fixation for displaced mid-shaft clavicle fractures: a systematic review
por: Houwert, R. Marijn, et al.
Publicado: (2011)

Mode of delivery in non-cephalic presenting twins: a systematic review
por: Steins Bisschop, Charlotte N., et al.
Publicado: (2012)

Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study
por: Hiensch, Anouk E., et al.
Publicado: (2022)

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
por: de Wit, R., et al.
Publicado: (1998)

Cancer-related fatigue: clinical practice versus practice guidelines
por: Hilarius, Doranne L., et al.
Publicado: (2010)

Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer
por: Bijlsma, Rhode, et al.
Publicado: (2020)

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.
por: Dercksen, M. W., et al.
Publicado: (1993)

Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.
por: Hanauske, A. R., et al.
Publicado: (1996)

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide.
por: Herben, V. M., et al.
Publicado: (1997)

Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients
por: Malingré, M M, et al.
Publicado: (2001)

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
por: de Wit, R., et al.
Publicado: (1995)

Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary
por: Wright-McNaughton, Morag, et al.
Publicado: (2019)

Invasive placentation and uterus preserving treatment modalities: a systematic review
por: Steins Bisschop, Charlotte N., et al.
Publicado: (2011)

A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma
por: Arends, J J, et al.
Publicado: (2005)

Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.
por: Sternberg, C. N., et al.
Publicado: (1994)

Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.
por: de Wit, R., et al.
Publicado: (1998)

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups.
por: McLeod, H. L., et al.
Publicado: (1996)

Oral topotecan: bioavailability and effect of food co-administration
por: Herben, V M M, et al.
Publicado: (1999)

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
por: de Wit, R., et al.
Publicado: (1997)

Participation in and adherence to physical exercise after completion of primary cancer treatment
por: Kampshoff, Caroline S., et al.
Publicado: (2016)

Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial
por: Velthuis, Miranda J, et al.
Publicado: (2010)

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer
por: Helgason, H H, et al.
Publicado: (2006)

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients
por: Malingré, M M, et al.
Publicado: (2001)

Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trial.
por: Elferink, F., et al.
Publicado: (1987)

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks
por: Kerbusch, T, et al.
Publicado: (2004)

Acute and Delayed Effects of Fatigue on Ground Reaction Force, Lower Limb Stiffness and Coordination Asymmetries During a Landing Task
por: Knihs, Débora Aparecida, et al.
Publicado: (2021)

The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy
por: Schuurhuizen, Claudia SEW, et al.
Publicado: (2018)

Manufacturers’ views on outcome-based agreements
por: Barjestehvan Waalwijk van Doorn-Khosrovani, Sahar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qhrmeu142oredsdm0rrnoai11k